Article info
PDFOriginal research
Shortages and price variability of essential cytotoxic medicines for treating children with cancers
- Correspondence to Kotoji Iwamoto; iwamotok{at}who.int
Citation
Shortages and price variability of essential cytotoxic medicines for treating children with cancers
Publication history
- Received June 29, 2020
- Revised August 14, 2020
- Accepted August 28, 2020
- First published November 10, 2020.
Online issue publication
February 20, 2023
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© World Health Organization 2020. Licensee BMJ. https://creativecommons.org/licenses/by/3.0/igo/This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (CC BY 3.0 IGO), which permits use, distribution,and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article’s original URL.Disclaimer: The author is a staff member of the World Health Organization. The author alone is responsible for the views expressed in this publication and they do not necessarily represent the views, decisions or policies of the World Health Organization.